Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

McKesson Cardiology Hemo Recalled by McKesson Israel Ltd. Due to Change Healthcare has identified an issue where, under...

Date: March 12, 2018
Company: McKesson Israel Ltd.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact McKesson Israel Ltd. directly.

Affected Products

McKesson Cardiology Hemo, Release SW version 13.0. Used for physiological monitoring, image and data processing. McKesson Cardiology Hemo is intended for complete physiological/hemodynamic monitoring, clinical data acquisition, medical image and data processing, and analytical assessment. McKesson Cardiology Hemo is also intended for patient/procedural data management, such as documentation, logging, reporting, trending, storing, reviewing, carrying out clinical calculations and exporting various representations of the acquired data.

Quantity: 31 units

Why Was This Recalled?

Change Healthcare has identified an issue where, under certain circumstances, the Real Time Monitor (RTM) may not display physiological signals.

Where Was This Sold?

This product was distributed to 14 states: CA, CO, CT, FL, GA, IN, KS, LA, NJ, NY, OH, OK, SC, TX

Affected (14 states)Not affected

About McKesson Israel Ltd.

McKesson Israel Ltd. has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report